Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fiven ASA - Fourth Quarter Results 2023

· The total revenues in Q4 2023 reached EUR 35.7m, a sequential improvement from Q3-2023 of 3.3% and a reduction of -22.8% versus Q4 2022. Excluding exceptional one-off sales in Q4 2022, organic variation of sales amounts to -15.5%. Vs Q4 2021, organic variation from revenues amounts to -3.7%. · The adjusted EBITDA was EUR 9.6m, in line with the reported Q3 2023 result of EUR 9.7m and compared to EUR 20.3m in Q4 2022. Excluding exceptional one-offs in Q4 2022, organic variation amounts to -33.5%. Versus Q4 2021, the organic EBITDA improvement amounts to +37.3%. · In a market

Saab receives Gripen order for Hungary

Saab has today signed a contract with the Swedish Defence Materiel Administration (FMV) and received an order for four additional Gripen C fighter aircraft for Hungary.This order follows an amendment to the contract between FMV and the Hungarian Government signed in December 2001 regarding 14 Gripen C/D fighters for the Hungarian Air Force. The contract amendment for the four additional aircraft was signed by the Hungarian Ministry of Defence and FMV on 23 February 2024. With this new contract amendment, Hungary will operate a total of 18 Gripen C/D aircraft to protect and defend the

Shared values strengthen the partnership between KraftPal and Kiilto

Cardboard pallet manufacturer KraftPal uses Kiilto’s biobased adhesive in its production, and Kiilto uses KraftPal’s cardboard pallets in the transportation of some of its products.  Environmental values and a responsible business approach are key priorities for both companies.KraftPal  manufactures cardboard pallets for logistic purposes. The company’s cardboard pallets also offer an alternative to traditional wooden pallets. Cardboard pallets are not only durable, but also fully recyclable and lightweight. Despite their light structure, they can hold up to over

No. 23, 2024 – Nordea Kredit Realkreditaktieselskab drawings as per 1 April 2024

Nordea Kredit hereby announces drawings data for callable Mortgage Credit Bonds (RO) and Covered Mortgage Credit Bonds (SDRO) as per 1 April 2024. The figures are published in order to comply with publication requirements in the transparency regulation 2017/1129/EU and the Danish Act on Capital Markets section 24.   Questions can be directed to Torben Jurlander phone +45 55 47 41 99.     Yours faithfully   Nordea Kredit Realkreditaktieselskab

Notice of Annual General Meeting

Valby, Denmark, 23 February 2024 - Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on:  Wednesday, 20 March 2024 at 10:00 am CET   The annual general meeting will be held at the offices of the Company at:  H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby  Agenda  In accordance with Article 8.1 of the Articles of Association, the agenda of the meeting is as follows:  1. Report of the Board of Directors on the Company’s activities during the past year. 2. Presentation and adoption of the annual report. 3. Resolution on the appropriation of

Pagero Group AB applies for de-listing

Since Thomson Reuters Corporation, through its wholly-owned subsidiary Thomson Reuters Finance S.A. ("Thomson Reuters"), controls more than 99 per cent of the shares and votes in Pagero Group AB (publ) (“Pagero” or the “Company”) and has initiated compulsory redemption of the remaining shares and warrants in the Company, the Board of Directors of Pagero has resolved to apply for de-listing of the Company’s shares from Nasdaq First North Growth Market.On 12 February 2024, Thomson Reuters announced that it controls 99.45 per cent of all shares and votes in Pagero following the public offer

Nordhealth AS - Invitation to Q4 2023 presentation

Nordhealth will report and present its Q4 2023 results on Tuesday the 5[th] of March 2024.The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Mari Orttenvuori on the 5[th] of March at 13:00 CET. Please use the following link to attend: https://us02web.zoom.us/j/83057714357 The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q4/2023 and the 2H/2023 interim financial report will be available on 5 March 2024 at 07:30 am CET on www.newsweb.no and on Nordhealth's IR  website

Scholarships drive student success in AI and data science

Students offered scholarships to study artificial intelligence (AI) and data science at Teesside University have shared how the support is helping them to progress in their careers.Teesside University launched 20 scholarships last year to support students from under-represented backgrounds to study postgraduate degrees in AI and data science. Teesside was one of 30 UK institutions chosen by the Office for Students (OfS) to receive a share of £8.1m funding from the Department for Science, Innovation and Technology (DSIT) and Office for Artificial Intelligence (OAI) to tackle digital

Munters Annual and Sustainability Report 2023

Munters Group AB´s (NASDAQ:MTRS) Annual and Sustainability Report 2023 has been published on www.munters.com in English and Swedish. The report can be downloaded here: https://www.munters.com/en/investor-relations/financial-reports/. The Swedish Annual and Sustainability Report is also available on the website in European Single Electronic Format (ESEF). The report has also been printed in a limited edition and can be ordered from investorrelations@munters.com. This information is information that Munters Group AB is obliged to make public pursuant to the Securities Markets Act.The

Prolight Diagnostics CEO to BioStock: "We deliver on all goals”

Prolight Diagnostics' year-end report for 2023 shows that the company met all the goals for the year. The company's point-of-care analysis system has shown proof-of-performance for measurement of troponin in whole blood. In addition, the company has formed a Clinical Advisory Board and established an R&D manufacturing line for the upcoming pilot production. The goal for 2024 is to complete the development of the system for clinical validation.Read the full article at biostock.se : https://www.biostock.se/en/2024/02/prolight-diagnostics-ceo-we-deliver-on-all-

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 43 – 23 FEBRUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation

Mölndal, Sweden – February 23, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its third quarter 2023/24 results on February 29, 2024 at 14:00 CEST.Integrum’s CEO Rickard Brånemark will present the report together with CFO Jörgen Svanström and US President Jeffrey Zanni in a webcast. The presentation will be held in English. Time: Thursday, February 29, 2024 at 14:00 CEST. Location: Webcast (see link below). The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/ The webcast and

Flowscape wins contract with large Finnish company

A large Finnish company chooses Flowscapes smart office solution for its offices in Europe. The order value of the initial three offices amounts to EUR 147,000 (SEK 1,650,000) in the first year and there after EUR 64,000 (SEK 745,000) annually recurring."We are happy and proud that this customer decided for Flowscape's smart office solution for their offices. The customer already had an existing solution from another supplier that they now chose to replace with Flowscape’s solution. The customer has more than 10 offices in Europe and the orders now received are for three offices. We have

Invitation to webcast – presentation of fourth quarter 2023 result

Solstad Offshore welcomes to presentation of its 4Q 2023 report, Friday, March 1st, 2024, at 09:00 am. The presentation will be held by Lars Peder Solstad and Kjetil Ramstad. 4Q 2023 report will be released Thursday, February 29th, 2024, and made available on www.solstad.com and www.newsweb.no. Solstad 4Q 2023 presentation: Date: Friday, March 1st, 2024 Time: 09:00 a.m. CEST Format: Live webcast Language: English Link: https://channel.royalcast.com/landingpage/hegnarmedia/20240301_2/ A recorded version will be made available at https://www.solstad.com Skudeneshavn,

Axfood publishes Annual and Sustainability Report 2023

Axfood’s Annual and Sustainability Report 2023 has been published and is now available on the Group’s website.– In changing times, another successful year for Axfood is summarised with high growth, increased market share and major strides towards increased competitiveness through investments in digitalisation, automation and the customer offering. Our business model remains strong despite significant changes in market dynamics and it is clear that more people have come to appreciate our concepts and offerings. This provides us with excellent conditions for continued long-term, profitable

Lundbeck announces changes to Executive Management

Lundbeck announces changes to Executive Management Valby, Denmark, February 23, 2024 - H. Lundbeck A/S (Lundbeck) today announced the following changes in the Executive Management team. Jacob Tolstrup, Executive Vice President, Commercial Operations will leave Lundbeck no later than March 1, 2024. Jacob Tolstrup joined Lundbeck in 1999 and has held various management positions across the company, becoming a member of Lundbeck’s Executive Management team in 2012. “We would like to express gratitude to Jacob for his long-standing commitment to Lundbeck. Jacob has been a valuable

Cereno Scientific releases Insights Videos Season 3 Episode 5 with Dr. Raymond Benza, System Director of Pulmonary Hypertension, Mount Sinai Health System

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 5 of Season 3 in the Insights Video Series has been released. In the video, recorded at the Pulmonary Vascular Research Institute (PVRI) Annual Congress 2024, Dr. Raymond Benza, System Director of Pulmonary Hypertension at Mount Sinai Icahn School of Medicine, New York City, Principal Investigator of the Phase II study of CS1, and member of Cereno’s Scientific Advisory Board, talks about what “Compassionate Use” is and how the

Solwers Plc issues 58,071 new shares

Solwers Plc Company Release 23.02.2024 at 09.45 a.m. EEST Solwers Plc announced on 29 January 2024 that it is expanding the range of services offered to the industry by acquiring the entire share capital of the Swedish Relitor Engineering AB. Part of the purchase price was agreed to be paid with Solwers Plc’s shares. The total number of shares directed to the sellers is 58,071 shares. The 58,071 new shares have today been registered in the trade register maintained by the Finnish Patent and Registration Office and the total number of shares issued by Solwers Plc increases from 9,946,

Tobii’s intended rights issue fully covered by subscription and guarantee undertakings

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN TOBII AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.Tobii AB (publ) today announces that its intended rights issue of approximately SEK 300 million is fully covered by subscription and guarantee undertakings.

The subscription period in Curasight’s rights issue begins today

Copenhagen, Denmark, 23 February 2024 - Today is the first day of the subscription period in Curasight A/S’s ("Curasight" or the “Company" – TICKER: CURAS) new issue of shares with preferential rights for the Company's existing shareholders of up to DKK 51.2 million before transaction costs (the “Rights Issue"), which was resolved by the Board of Directors on 13 February 2024.Summary of the Rights Issue · Each existing share in the Company, as of the record date on 22 February 2024, entitles the holder to one (1) subscription right. Seven (7) subscription rights entitle the holder to

Ellos Group AB (publ) interim report January - December 2023

Press release, Borås, 23 February 2024   The interim report for Ellos Group AB (publ) is published today. THE FOURTH QUARTER 2023 • Net sales decreased by 4.7 % to SEK 993.6 (1 042.2) million. Organically, net sales decreased by 4.5 %. • The gross margin increased to 51.8 (49.3) %. • Adjusted EBITA increased to SEK 73.5 (26.5) million. The adjusted EBITA margin increased to 7.4 (2.5) %. • The operating profit/loss increased to SEK 42.3 (-11.6) million. The operating margin increased to 4.3 (-1.1) %. • Cash flow from operating activities amounted to SEK 157.2 (68.6)

Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO

Press Release – Oslo, Norway, February 23, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that that the international multicenter Phase III clinical study of Cevira[®] (APL-1702), the non-surgical treatment in development for cervical high-grade squamous intraepithelial lesions (HSIL), has been selected for late breaking oral presentation at the 2024 SGO Annual Meeting on Women’s Cancer of the Society of Gynecologic Oncology, to be held March 16-18 in San Diego, CA, USA:· Oral presentation:

Heliospectra (publ) Publish the Year-End Report for 2023

(GOTHENBURG, Sweden, Feb 23, 2024, at 08:30 CET)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Year-End Report for 2023.Full report is enclosed to this press release and is also uploaded at https://heliospectra.com/investor-relations/financial-reports-documents/reports/. SUMMARY OF REPORT Sales and financial performance October – December 2023 · Order intake during the period amounted to SEK 9,377 (12,677) thousand. · Net sales during the period amounted to SEK 9,908 (9,998) thousand.

There are no items matching the current filter
There are no more items matching the current filter
Back to top